Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.7 USD | -1.51% | -0.46% | +15.68% |
Financials (USD)
Sales 2024 * | 433M | Sales 2025 * | 659M | Capitalization | 6.68B |
---|---|---|---|---|---|
Net income 2024 * | -151M | Net income 2025 * | -92M | EV / Sales 2024 * | 14.3 x |
Net cash position 2024 * | 514M | Net cash position 2025 * | 444M | EV / Sales 2025 * | 9.46 x |
P/E ratio 2024 * |
-48.5
x | P/E ratio 2025 * |
-73
x | Employees | 645 |
Yield 2024 * |
-
| Yield 2025 * |
0.94% | Free-Float | 99.14% |
Latest transcript on Blueprint Medicines Corporation
1 day | -1.51% | ||
1 week | -0.46% | ||
Current month | +16.82% | ||
1 month | +15.66% | ||
3 months | +39.40% | ||
6 months | +81.31% | ||
Current year | +15.68% |
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Director of Finance/CFO | 52 | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 16-04-13 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Lonnel Coats
BRD | Director/Board Member | 58 | 16-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 0 M€ | 0.00% | - | |
0.24% | 0 M€ | 0.00% | - | |
0.18% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 106.7 | -1.51% | 406,715 |
24-05-09 | 108.3 | -0.40% | 553,293 |
24-05-08 | 108.8 | +0.21% | 478,493 |
24-05-07 | 108.6 | +2.16% | 755,189 |
24-05-06 | 106.2 | -0.88% | 803,183 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.68% | 6.68B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- BPMC Stock